About Biolytic Lab
Biolytic Lab is a company based in Fremont (United States) founded in 1993. Biolytic Lab offers products and services including Dr. Oligo 12, Dr. Oligo 48, Dr. Oligo 192XLc, Dr. Oligo 768XLc, and Synthesis Consumables. Biolytic Lab operates in a competitive market with competitors including Twist Bioscience, Ansa Biotechnologies, Nutcracker Therapeutics, DNA Script and Sensible Biotechnologies, among others.
- Latest Funding Round$25.51K (USD), Grant
Sep 2019
- Investors
Products & Services of Biolytic Lab
Biolytic Lab offers a comprehensive portfolio of products and services, including Dr. Oligo 12, Dr. Oligo 48, Dr. Oligo 192XLc, Dr. Oligo 768XLc, and Synthesis Consumables.
Low throughput device for DNA and RNA oligo synthesis.
Medium throughput synthesizer for DNA and RNA applications.
High throughput tool for large-scale DNA and RNA production.
High throughput synthesizer for extensive oligo synthesis needs.
Materials for DNA and RNA synthesis processes.
Apps and channels of Biolytic Lab
its YouTube channel Biolytic Lab Performance Inc. has 330 subscribers and 15 videos.
Videos from Biolytic Lab
The most watched videos on Biolytic Lab's YouTube channel, Biolytic Lab Performance Inc. (330 subscribers). Click a video to play it here.
More on Biolytic Lab Performance Inc..
Funding Insights of Biolytic Lab
- Total Rounds 2
- Last Round Grant — $25,509
- First Round $213,601
(Sep 2016)
- Investors Count 1
All 2 funding rounds of Biolytic Lab with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
1 investors in total: 1 institutional.
Investors in Biolytic Lab
Biolytic Lab has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - |
Investor details for Biolytic Lab
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Biolytic Lab
6 people are tracked at Biolytic Lab (2 in leadership, 4 in team).
| Name | Role | Group |
|---|---|---|
Kim Edmonds | Director of Finance & Administration | Leadership |
James Demmitt, MBA | CEO | Leadership |
Gregory Greenleaf | Software Engineer | Team |
Justin Lee | Manufacturing Engineer | Team |
Jeffery Demmitt | Research Development Project Engineer | Team |
Francis Carreon | Mechanical Engineer, R&d | Team |
Complete people profiles for Biolytic Lab
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Biolytic Lab
3 dated milestones of Biolytic Lab across 26 years, from founding to its latest funding, stage changes and deals.
- Founded Biolytic Lab is founded.
- Funding First funding round of $214K.
- Funding Latest funding round, Grant, of $26K.
Competitors of Biolytic Lab
Biolytic Lab operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Twist Bioscience, Ansa Biotechnologies, Nutcracker Therapeutics, DNA Script and Sensible Biotechnologies, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| twistbioscience.com | 2013 | San Francisco, United States | $245.81M | 919 | Synthetic DNA is synthesized via a semiconductor-based platform. | |
| ansabio.com | 2017 | Berkeley, United States | $175.5M | 253 | DNA synthesis technology using enzymes is provided. | |
| nutcrackerx.com | 2018 | Emeryville, United States | $227.04M | – | mRNA therapeutics are developed via proprietary biochip platforms. | |
| dnascript.com | 2014 | Paris, France | $301.69M | – | Benchtop DNA printers for nucleic acid synthesis are developed. | |
| sensible.bio | 2021 | Wilmington, United States | $4.33M | – | Developer of mRNA technology for therapeutics and vaccines | |
| synplechem.com | 2016 | Zurich, Switzerland | $10,200 | – | Automated chemical synthesizers are developed using reagent capsules. | |
| mesabiotech.com | 2009 | San Diego, United States | $26.8M | 131 | Point-of-care molecular diagnostic kits are developed and supplied. | |
| oriciro.com | 2018 | Tokyo, Japan | $10.87M | – | Technologies for DNA synthesis and amplification are developed. | |
| cambriangenomics.com | 2011 | San Francisco, United States | $11.23M | – | Developers of technology for laser printing DNA | |
| genomadix.com | 2021 | Ottawa, Canada | – | – | Developer of a portable molecular analyzer for diagnostic purposes |
Detailed competitors of Biolytic Lab
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Biolytic Lab
The website of Biolytic Lab (biolytic.com) receives about 5.8K visits a month.
- Monthly visits5.8K
▲ 6.8% vs previous month
Websites whose visitors overlap most with Biolytic Lab. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
bvascientific.com | bvascientific.com | 100% | – | – | – |
| heidolph-instruments.com | 62% | – | #7,170,621 | View details |
Latest news on Biolytic Lab
Complete news archive for Biolytic Lab
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Biolytic Lab
10 companies that operate in the same segment as Biolytic Lab (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Biolytic Lab
Biolytic Lab was founded in 1993 and raised its 1st funding round 23 years after it was founded.
Biolytic Lab is headquartered in Fremont, United States. It is registered at Fremont, California, United States.
Provider of DNA and RNA oligonucleotide synthesis systems. The companys Dr. Oligo line of DNA synthesizers can be used for Oligonucleotide and Gene synthesis, PCR RT-PCR, siRNA RNAi, DNA RNA sequencing, Immunity and Biochemistry, High-Throughput screening, Natural Product Biosynthesis, Gene Construction, Reverse Transcription PCP, Hybridization, SNPS, other diagnostic or therapeutic research. The company also manufactures the Dr. Oligo Processor for cost-effective, automated desalting and oligo purification.
Biolytic Lab's top competitors include Twist Bioscience, Ansa Biotechnologies and Sensible Biotechnologies.
Biolytic Lab offers Dr. Oligo 12, Dr. Oligo 48, Dr. Oligo 192XLc, Dr. Oligo 768XLc, and Synthesis Consumables.
Biolytic Lab has 1 investor. Key investors include HHS.
Biolytic Lab operates through Biolytic Lab Performance Inc.